Intellectual property and its role in the pharmaceutical industry.
作者信息
Atkinson Jonathan D M, Jones Rachel
出版信息
Future Med Chem. 2009 Dec;1(9):1547-50. doi: 10.4155/fmc.09.138.
PMID:21425976
Abstract
摘要
相似文献
1
Intellectual property and its role in the pharmaceutical industry.
Future Med Chem. 2009 Dec;1(9):1547-50. doi: 10.4155/fmc.09.138.
2
Intellectual property. Fixing the legal framework for pharmaceutical research.知识产权。完善药物研究的法律框架。
Science. 2010 Feb 26;327(5969):1083-4. doi: 10.1126/science.1184188. Epub 2010 Feb 11.
3
Auctioning the cure.拍卖治疗方法。
Nat Med. 2011 May;17(5):528-30. doi: 10.1038/nm0511-528.
4
Pills, patents, and power: state creation of gray markets as a limit on patent rights.药丸、专利与权力：国家创设灰色市场作为对专利权的限制。
Fla J Int Law. 2002 Spring;14(2):217-60.
5
An overview of pharmaceutical cocrystals as intellectual property.药物共晶体作为知识产权概述。
Mol Pharm. 2007 May-Jun;4(3):301-9. doi: 10.1021/mp070001z. Epub 2007 May 4.
6
Intellectual property. U.S. Court opens door to free trade in ideas.知识产权。美国法院为思想的自由贸易打开大门。
Science. 2003 Sep 19;301(5640):1643. doi: 10.1126/science.301.5640.1643.
7
[Intellectual property rights and right of access to medicines].[知识产权与药品获取权]
Med Trop (Mars). 2006 Dec;66(6):526-8.
8
Enforcing pharmaceutical and biotech patent rights in China.在中国实施制药和生物技术专利权。
Nat Biotechnol. 2008 Nov;26(11):1235-40. doi: 10.1038/nbt1108-1235.
9
Realizing two-tiered innovation policy through drug regulation.通过药品监管实现两级创新政策。
Stanford Law Rev. 2006 Feb;58(4):1221-50.
10
A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.美国制药行业中对映体的可专利性考量。
Chirality. 2008 Jun;20(6):762-70. doi: 10.1002/chir.20520.
Zotero 插件